John Russel Denton
Senior Vice President, General Counsel, and Secretary · Caris Life Sciences, Inc.
- 2025
- Sep 23, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John Russel Denton files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Baxley Spetzler - $14.84M in CAI purchases and sales in the last 12 months
- Brian J. Brille - $12.13M in CAI purchases and sales in the last 12 months
- Jon Halbert - $990K in CAI purchases and sales in the last 12 months
- Jeff L. Vacirca - $501K in CAI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John Russel Denton?
John Russel Denton is a corporate insider, tracked as Senior Vice President, General Counsel, and Secretary of Caris Life Sciences, Inc. (CAI). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John Russel Denton submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has John Russel Denton been buying or selling stock?
Recorded transactions: 1 open-market purchase ($101K) and 1 open-market sale ($239K) across all tracked filings.
